| Turquia | Austria | Spanyol | |
| Terapi Aktinium-225 | dari $22,955 | dari $55,000 | dari $45,000 |
| Operasi melanoma | dari $3,500 | dari $9,500 | dari $4,500 |
| Imunoterapi dengan Keytruda (Pembrolizumab) | dari $3,300 | dari $15,000 | dari $15,000 |
| Bedah mikro Mohs | dari $2,200 | dari $4,000 | dari $2,200 |
| Terapi topikal melanoma | dari $1,450 | - | dari $6,456 |
900+ prosedur melanoma telah dilakukan – Dr. Bülent Karagöz berspesialisasi dalam imunoterapi dan terapi target di Anadolu Medical Center.
Prof. Dr. Eda Tanrikulu berspesialisasi dalam melanoma maligna metastatik dan memegang peran kepemimpinan dalam evaluasi kasus kanker di Anadolu Medical Center.
Mustafa Solak telah melakukan 1.100+ perawatan kanker, termasuk melanoma, di Hisar Hospital Intercontinental.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.